Dissemination of C. neoformans to the central nervous system: Role of chemokines, Th1 immunity and leukocyte recruitment

Journal of NeuroVirology

Volumn 5, Issue 1, 1999, Pages 76-81

  Huffnagle, Gary B ^a   McNeil, Lisa K ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

CCR5; Cryptococcus; Lymphocytes; Macrophage inflammatory proiein 1

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR5; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; POLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CENTRAL NERVOUS SYSTEM; CLEARANCE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; EFFECTOR CELL; HELPER CELL; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNITY; INFECTION; INFLAMMATION; KNOCKOUT MOUSE; LEUKOCYTE ACTIVATION; LUNG; MEMORY CELL; MONOCYTE; MOUSE; NEUROTROPISM; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYSTEM; SURVIVAL;

ANIMALIA; FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 0032918671     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289909029748     Document Type: Article

References (38)

1. Aguirre K, Havell EA, Gibson GW, Johnson LL (1995). Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect Immun 63: 1725-1731.
2. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA (1996). CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272: 1955-1958.
3. Barluzzi R, Mazzolla R, Brozzetti A, Puliti M, Mariucci G, Mosci P, Bistoni F, Blasi E (1997). A low virulent strain of Candida albicans enhances brain anticryptococcal defenses: characterization of the local immune reaction by RT-PCR and histochemical analysis. J Neuroimmunol 79: 37-48.
4. Blasi E, Barluzzi R, Mazzolla R, Mosci P, Bistoni F (1992). Experimental model of intracerebral infection with Cryptococcus neoformans: roles of phagocytes and opsonization. Infect Immun 60, 3682-3688.
5. Blasi E, Mazzolla R, Barluzzi R, Mosci P, Bistoni F (1994). Anticryptococcal resistance in the mouse brain: beneficial effects of local administration of heat-inactivated yeast cells. Infect Immun 62: 3189-3196.
6. Bonecchi R, Bianchi G, Bordignon PP, D DA, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, Mantovani A, Sinigaglia F (1998). Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (This) and Th2s. J Exp Med 187: 129-134.
7. Casadevall A (1995). Antibody immunity and invasive fungal infections. Infect Immun 63: 4211-4218.
8. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR (1996). Identification of a major coreceptor for primary isolates of HIV-1. Nature 381: 661-666.
9. Diamond RD (1995). Cryptococcus neoformans. In: Principles and Practice of Infectious Diseases Mandell GL, Bennett JE, Dolin R (edis), Churchill Livingstone, New York, pp 2331-2340.
10. Doyle HA, Murphy JW (1997). MIP-1 alpha contributes to the anticryptococcal delayed-type hypersensitivity reaction and protection against Cryptococcus neoformans. J Leukoc Biol 61: 147-155.
11. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA (1996). HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CG- CKR-5 [see comments]. Nature 381: 667-673.
12. Hill JO (1992). CD4+ T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract. J Exp Med 175: 1685-1695.
13. Hill JO, Aguirre KM (1994). CD4+ T cell-dependent acquired state of immunity that protects the brain against Cryptococcus neoformans. J Immunol 152: 2344-2350.
14. Hill JO, Harmsen AG (1991). Intrapulmonary growth and dissemination of an avirulent strain of Cryptococcus neoformans in mice depleted of CD4+ or CD8+ T cells. J Exp Med 173: 755-758.
15. Hoag KA, Street NE, Huffnagle GB, Lipscomb MF (1995). Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. Am J Respir Cell Mol Biol 13: 487-495.
16. Huffnagle GB, Chen GH, Curtis JL, McDonald RA, Strieter RM, Toews GB (1995a). Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. J Immunol 155: 3507-3516.
17. Huffnagle GB, Lipscomb MF (1998). Cells and cytokines in pulmonary cryptococcosis. Res Immunol 149: 387-396.
18. Huffnagle GB, Lipscomb MF, Lovchik JA, Hoag KA, Street NE (1994). The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J Leukoc Biol 55: 35-42.
19. Huffnagle GB, Strieter RM, McNeil LK, McDonald RA, Burdick MD, Kunkel SL, Toews GB (1997). Macrophage inflammatory protein-lalpha (MIP-1alpha) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection. J Immunol 159: 318-327.
20. Huffnagle GB, Strieter RM, Standiford TJ, McDonald RA, Burdick MD, Kunkel SL, Toews GB (1995b). The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection. J Immunol 155: 4790-4797.
21. Huffnagle GB, Toews GB, Burdick MD, Boyd MB, McAllister KS, McDonald RA, Kunkel SL, Strieter RM (1996). Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. J Immunol 157: 4529-4536.
22. Huffnagle GB, Yates JL, Lipscomb MF (1991a). Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells. J Exp Med 173: 793-800.
23. Huffnagle GB, Yates JL, Lipscomb MF (1991b). T cell-mediated immunity in the hing: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice. Infect Immun 59: 1423-1433.
24. Koike K, Sakamoto Y, Kiyama H, Masuhara K, Miyake A, Inoue M (1997). Cytokine-induced neutrophil chemoattractant gene expression in the rat hypothalamus by osmotic stimulation. Brain Res Mol Brain Res 52: 326-329.
25. Kozel TR (1993). Activation of the complement system by the capsule of Cryptococcus neoformans. Curr Top Med Mycol 5: 1-26.
26. Kunkel SL, Strieter RM, Lindley IJ, Westwick J (1995). Chemokines: new ligands, receptors and activities. Immunol Today 16: 559-561.
27. Kwon-Chung KJ, Polacheck I, Popkin TJ (1982). Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J Bacteriol 150: 1414-1421.
28. Lee SC, Dickson DW, Casadevall A (1996). Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications. Hum Pathol 27: 839-847.
29. Levitz SM, North EA (1997). Lymphoproliferation and cytokine profiles in human peripheral blood mononuclear cells stimulated by Cryptococcus neoformans. J Med Vet Mycol 35: 229-236.
30. Lipovsky MM, Gekker G, Hu S, Ehrlich LC, Hoepelman AI, Peterson PK (1998). Gryptococcal glucuronoxylomannan induces interleukin (IL)-8 production by human microglia but inhibits neutrophil migration toward IL-8. J Infect Dis 177: 260-263.
31. Loetscher P, Uguccioni M, Bordoli L, Baggiolini M, Moser B, Chizzolini C, Dayer JM (1998). CCR5 is characteristic of Th1 lymphocytes [letter]. Nature 391: 344-345.
32. Qin S, Rottman JB, Myers P, Kassam N, Weintlatt M, Loetscher M, Koch AE, Moser B, Mackay CR (1998). The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 101: 746-754.
33. Retini C, Vecchiarelli A, Monari C, Tascini C, Bistoni F, Kozel TR (1996). Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils. Infect Immun 64: 2897-2903.
34. Rottman JB, Ganley KP, Williams K, Wu L, Mackay CR, Ringler DJ (1997). Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection Am J Pathol 151: 1341-1351.
35. Salas SD, Bennett JE, Kwon-Chung KJ, Perfect JR, Williamson PR (1996). Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans. J Exp Med 184: 377-386.
36. Salkowski CA, Balish E (1990). Pathogenesis of Cryptococcus neoformans in congenitally immunodeficient beige athymic mice. Infect Immun 58: 3300-3306.
37. Samson M, Labbe O, Mollereau C, Vassart G, Parmentier M (1996). Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 35: 3362-3367.
38. Vecchiarelli A, Retini C, Pietrella D, Monari C, Tascini C, Beccari T, Kozel TR (1995). Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes. Infect Immun 63: 2919-2923.